Status:
TERMINATED
Efficacy of N-acetylcysteine on the Craving Symptoms of Abstinent Hospitalized Patients With Cocaine Addiction
Lead Sponsor:
Salvatore Campanella
Conditions:
Cocaine Addiction
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
Brief Summary
Cocaine abuse is associated with serious physical, psychiatric and social problems. Addiction results in the compulsive use of a substance with loss of control and persistence despite the negative con...
Detailed Description
Cocaine abuse is associated with serious physical, psychiatric and social problems. Addiction results in the compulsive use of a substance with loss of control and persistence despite the negative con...
Eligibility Criteria
Inclusion
- Patients addicted to cocaine (according to the DSM V classification)
- Patients admitted for three weeks in the unit 73 of the CHU Brugmann Hospital
- French speaking
Exclusion
- Anti-craving or anti-psychotic medication
- Addiction to other drugs (except nicotine or cannabis)
- Neurological medical history
- Psychiatric medical history
- Heavy medical history
- Asthma
- Pregnancy
- Lactose intolerance
Key Trial Info
Start Date :
March 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 17 2024
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT03423667
Start Date
March 1 2019
End Date
December 17 2024
Last Update
February 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Brugmann
Brussels, Belgium, 1020